March 17, 2026

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Conexiant

March 13, 2026

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Conexiant

March 09, 2026

US Adolescent Sleep Loss Worsens Over 16 Years

Increase was driven largely by rising rates of very short sleep among high school students, with trends seen across demographic and behavioral groups.

Conexiant

March 09, 2026

Which Viruses Hit Kids Hardest?

Study compares pathogen type, comorbidities, and clinical severity in pediatric admissions

Conexiant

March 06, 2026

Digital Tool Cuts Antibiotic Prescribing

Pragmatic trial finds digital decision support reduces antibiotic use in Rwandan health centers

Conexiant

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

March 02, 2026

Pediatricians at the Perioperative Helm

Pediatricians “uniquely positioned” to take active role in preanesthesia planning, says revised American Academy of Pediatrics report

Conexiant

February 27, 2026

Children With OSA Face Higher Influenza, COVID-19 Risk

Real-world analysis finds higher risk of influenza and COVID-19 diagnoses over five years, with no evidence of reduced risk after adenotonsillectomy

Conexiant

February 25, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

Conexiant

February 20, 2026

COVID Vaccine in Pregnancy: Link to Development? 

Multicenter study finds equivalent ASQ-3 scores at 18–30 months in offspring of vaccinated and unvaccinated mothers

Conexiant